QGEN Stock Might Gain Following New Partnership With ID Solutions

QIAGEN N.V. (QGEN) recently entered into a commercial partnership and co-marketing agreement with ID Solutions, a French provider of high-quality digital PCR (dPCR) assays, to expand the availability of dPCR assays for oncology research applications. The latest partnership is likely to expand QIAGEN’s position in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research.QGEN Stock’s Likely Trend Following the NewsFollowing the announcement, shares of QIAGEN remain ...